Prashanth Panduranga, Mukhaini Mohamed, Riyami Abdulla A, Sulaiman Kadhim, Shahrabani Rashid, Riyami Abdulla M
Department of Cardiology, Royal Hospital, Muscat, Sultanate of Oman.
Oman Med J. 2008 Oct;23(4):247-52.
To evaluate the clinical characteristics, angiographic profile, in-hospital and six-month clinical outcome of patients who underwent percutaneous coronary intervention in a tertiary hospital in the Sultanate of Oman.
Two hundred and five consecutive patients with both acute coronary syndrome and stable coronary artery disease, who underwent percutaneous coronary intervention between January 2007 and June 2007, were retrospectively analyzed. Follow-up information was obtained from outpatient visits of these patients at six-months.
The primary end point in this study was the occurrence of major adverse cardiovascular events (MACE), defined as cardiac death, any myocardial infarction (MI), cerebrovascular accident (CVA) and target vessel revascularization (TVR) with either repeat percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG). Secondary end points included angiographic success rate, procedural success rate, angina status, and the rate of clinical and angiographic restenosis.
The angiographic and procedural success rate was 98% and 95% respectively. Fifty-one percent of patients surveyed had single vessel disease, 34% had double vessel disease and triple vessel disease was seen in 15% of patients. Type A lesion was found in 16%, Type B in 55% and Type C in 29% of patients. The majority of patients had single vessel stenting (83%). The mean ± SD number of stents per patient was 1.6 ± 0.9.There were four in-hospital deaths (2%) and six patients (2.9%) had non-ST elevation myocardial infarction before hospital discharge. Out of 205 patients, 53 patients were lost to follow-up. Among the 148 patients followed up, 105 patients (71%) were asymptomatic at follow-up, 36 (24%) patients had stable angina and 7 (5%) had a late myocardial infarction including three patients with stent thrombosis (2%). Among the 43 patients with angina or late infarction, 28 patients underwent coronary angiogram. Angiographic in-stent restenosis was seen in 14 patients. Of them, 8 patients underwent CABG and 6 patients repeat PCI. Fourteen patients had patent stents.The remaining fifteen patients were on optimal medications including two patients with stent thrombosis as they refused coronary angiogram. Overall, 132 of 148 patients (105 asymptomatic/14 patent stents/13 with angina) (89%) were free from major adverse cardiac events. Considering anginal status and repeat angiograms, composite clinical (15 patients) and angiographic (14 patients) six-month restenosis rate in percutaneous coronary intervention patients (29/148) was 19.5%.
Results of percutaneous coronary intervention in our setup is excellent with good immediate results, low complication rate, good six-month clinical outcome and is comparable to international standards.
评估在阿曼苏丹国一家三级医院接受经皮冠状动脉介入治疗的患者的临床特征、血管造影情况、住院期间及六个月的临床结局。
回顾性分析2007年1月至2007年6月期间连续205例同时患有急性冠状动脉综合征和稳定型冠状动脉疾病并接受经皮冠状动脉介入治疗的患者。通过这些患者六个月的门诊随访获取随访信息。
本研究的主要终点是主要不良心血管事件(MACE)的发生,定义为心源性死亡、任何心肌梗死(MI)、脑血管意外(CVA)以及通过再次经皮冠状动脉介入治疗(PCI)或冠状动脉搭桥手术(CABG)进行的靶血管血运重建(TVR)。次要终点包括血管造影成功率、手术成功率、心绞痛状况以及临床和血管造影再狭窄率。
血管造影成功率和手术成功率分别为98%和95%。接受调查的患者中,51%患有单支血管病变,34%患有双支血管病变,15%的患者患有三支血管病变。16%的患者为A型病变,55%为B型病变,29%为C型病变。大多数患者进行了单支血管支架置入(83%)。每位患者置入支架的平均数量±标准差为1.6±0.9。有4例住院死亡(2%),6例患者(2.9%)在出院前发生非ST段抬高型心肌梗死。205例患者中,53例失访。在随访的148例患者中,105例(71%)在随访时无症状,36例(24%)患者有稳定型心绞痛,7例(5%)发生晚期心肌梗死,其中3例患者发生支架血栓形成(2%)。在43例有心绞痛或晚期梗死的患者中,28例进行了冠状动脉造影。14例患者出现血管造影支架内再狭窄。其中,8例患者接受了CABG,6例患者再次进行了PCI。14例患者支架通畅。其余15例患者接受了最佳药物治疗,其中2例支架血栓形成患者因拒绝冠状动脉造影而接受药物治疗。总体而言,148例患者中的132例(105例无症状/14例支架通畅/13例有心绞痛)(89%)无主要不良心脏事件。考虑到心绞痛状况和再次血管造影,经皮冠状动脉介入治疗患者(29/148)的综合临床(15例患者)和血管造影(14例患者)六个月再狭窄率为19.5%。
我们医院经皮冠状动脉介入治疗的结果非常好,即刻效果良好,并发症发生率低,六个月临床结局良好,与国际标准相当。